Paper21531982
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression.
Klampfl T and 18 others. Blood, 2011. Cited by 153 papers, by iCite.
Cite this record
ConductScience Library. Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression. Papers, record 21531982. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21531982
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genome-Wide Association Study | Major topic |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | Major topic |
| Myeloproliferative Disorders | Major topic |
| Oligonucleotide Array Sequence Analysis | Major topic |
| Chronic Disease | |
| Disease Progression | |
| Gene Expression Regulation, Leukemic | |
| Humans | |
| Janus Kinase 2 | |
| Karyotyping | |
| Point Mutation | |
| Polymorphism, Single Nucleotide |
Source PubMed
Cited by92
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 153 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42448935 | IKZF1N159S is associated with adverse outcomes in patients with myelodysplastic neoplasms. | Leukemia | 2026 | https://conductscience.org/library/papers/42448935 | PubMed |
| 42279423 | SNP-Based Chromosomal Microarray Analysis in the Era of Optical Genome Mapping: An Enriched Case-Series Evaluating Copy-Neutral Events. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42279423 | PubMed |
| 41939253 | Unraveling the role of TP53 mutations in myeloproliferative neoplasms: Molecular mechanisms of leukemic transformation. | Hemasphere | 2026 | https://conductscience.org/library/papers/41939253 | PubMed |
| 41717866 | Risk of Transformation to Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients With Myeloproliferative Neoplasms Over Attained Age and Time Since Diagnosis: A Nationwide Cohort Study. | Eur J Haematol | 2026 | https://conductscience.org/library/papers/41717866 | PubMed |
| 41212396 | The molecular management of classic myeloproliferative neoplasm. | J Egypt Natl Canc Inst | 2025 | https://conductscience.org/library/papers/41212396 | PubMed |
| 40542832 | Impact of ETV6 mutations on clinical outcomes in acute myeloid leukemia: a real-world retrospective cohort study. | Ann Hematol | 2025 | https://conductscience.org/library/papers/40542832 | PubMed |
| 40490510 | Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A. | Nat Genet | 2025 | https://conductscience.org/library/papers/40490510 | PubMed |
| 40164719 | Whole-genome sequencing of myeloproliferative neoplasms revealed dynamic clonal changes in the fibrotic or leukemic transformation and novel FOXP1 mutations in the fibrotic transformation. | Leukemia | 2025 | https://conductscience.org/library/papers/40164719 | PubMed |
| 40163809 | Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of JAK2-mutated post-MPN AML. | Blood | 2025 | https://conductscience.org/library/papers/40163809 | PubMed |
| 40076747 | High Mobility Group A1 Chromatin Keys: Unlocking the Genome During MPN Progression. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076747 | PubMed |
| 39598101 | Myeloproliferative Neoplasms: Challenging Dogma. | J Clin Med | 2024 | https://conductscience.org/library/papers/39598101 | PubMed |
| 38605095 | Cas9-directed long-read sequencing to resolve optical genome mapping findings in leukemia diagnostics. | Sci Rep | 2024 | https://conductscience.org/library/papers/38605095 | PubMed |
| 38308077 | Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms. | Sci Rep | 2024 | https://conductscience.org/library/papers/38308077 | PubMed |
| 38135698 | STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. | Cancer Gene Ther | 2024 | https://conductscience.org/library/papers/38135698 | PubMed |
| 37684235 | Shared and distinct genetic etiologies for different types of clonal hematopoiesis. | Nat Commun | 2023 | https://conductscience.org/library/papers/37684235 | PubMed |
| 37564898 | Treating accelerated and blast phase myeloproliferative neoplasms: progress and challenges. | Ther Adv Hematol | 2023 | https://conductscience.org/library/papers/37564898 | PubMed |
| 36845951 | Sclerosing extramedullary hematopoietic tumor of the colon: A case report and literature review. | Exp Ther Med | 2023 | https://conductscience.org/library/papers/36845951 | PubMed |
| 36834692 | IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater? | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36834692 | PubMed |
| 36632576 | Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies. | J Hematol | 2022 | https://conductscience.org/library/papers/36632576 | PubMed |
| 36568246 | Case report: Chronic neutrophilic leukemia associated with monoclonal gammopathies. A case series and review of genetic characteristics and practical management. | Front Oncol | 2022 | https://conductscience.org/library/papers/36568246 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CUX1 | 1523 | PubTator's text mining | https://conductscience.org/library/genes/1523 | NCBI Gene |
| ETV6 | 2120 | PubTator's text mining | https://conductscience.org/library/genes/2120 | NCBI Gene |
| FOXP1 | 27086 | PubTator's text mining | https://conductscience.org/library/genes/27086 | NCBI Gene |
| IKZF1 | 10320 | PubTator's text mining | https://conductscience.org/library/genes/10320 | NCBI Gene |
| JAK2 | 3717 | PubTator's text mining | https://conductscience.org/library/genes/3717 | NCBI Gene |
| RUNX1 | 861 | PubTator's text mining | https://conductscience.org/library/genes/861 | NCBI Gene |
| TET2 | 54790 | PubTator's text mining | https://conductscience.org/library/genes/54790 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21531982
GET https://conductscience.org/api/papers/v1/21531982/cited_by?page=2